Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 2

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Assessment of multimodal treatment options in recurrent and persistent acromegaly: a systematic review and meta-analysis

Maroufi, Seyed Farzad, Assar, Manijeh, Khorasanizadeh, MirHojjat, Sabet, Fatemeh Mahdavi, Sabahi, Mohammadmahdi, Dabecco, Rocco, Adada, Badih, Zada, Gabriel, Borghei-Razavi, Hamid·2024·Journal of Neuro-Oncology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11060-024-04658-7

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 26

  1. Bray DP, Mannam S, Rindler RS, Quillin JW, Oyesiku NM (2022) Surgery for acromegaly: Indications and goals.;13 · doi:10.3389/fendo.2022.924589
  2. Buchfelder M, Schlaffer SM (2017) The surgical treatment of acromegaly. Pituitary 20(1):76–83 · doi:10.1007/s11102-016-0765-7
  3. Kreutzer J, Vance ML, Lopes MBS, Laws ER (2001) Jr. Surgical Management of GH-Secreting Pituitary adenomas: an Outcome Study using Modern Remission Criteria. J Clin Endocrinol Metabolism 86(9):4072–4077 · doi:10.1210/jcem.86.9.7819 · Paper page
  4. Jagannathan J, Yen C-P, Pouratian N, Laws ER, Sheehan JP (2009) Stereotactic radiosurgery for pituitary adenomas: a comprehensive review of indications, techniques and long-term results using the Gamma Knife. J Neuro-Oncol 92(3):345–356 · DOI
  5. Sala E, Carosi G, Del Sindaco G, Mungari R, Cremaschi A, Serban AL et al (2021) Long-term remission of acromegaly after somatostatin analogues withdrawal: a single-centre experience. J Endocrinol Invest 44(12):2593–2599 · doi:10.1007/s40618-021-01562-z
  6. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clinical Res ed) 372:n71
  7. Coopmans EC, Postma MR, Wolters TLC, van Meyel SWF, Netea-Maier R, van Beek AP et al (2021) Predictors for remission after transsphenoidal surgery in Acromegaly: a Dutch Multicenter Study. J Clin Endocrinol Metab 106(6):1783–1792 · doi:10.1210/clinem/dgab069
  8. Babu H, Ortega A, Nuno M, Dehghan A, Schweitzer A, Bonert HV et al (2017) Long-term endocrine outcomes following endoscopic endonasal transsphenoidal surgery for Acromegaly and Associated Prognostic factors. Neurosurgery 81(2):357–366 · DOI
  9. Petrossians P, Tichomirowa MA, Stevenaert A, Martin D, Daly AF, Beckers A (2012) The Liege Acromegaly Survey (LAS): a new software tool for the study of acromegaly. Ann Endocrinol 73(3):190–201 · DOI
  10. Coopmans EC, van der Lely AJ, Neggers S (2022) Approach to the patient with treatment-resistant acromegaly. J Clin Endocrinol Metab 107(6):1759–1766 · doi:10.1210/clinem/dgac037
  11. Kyriakakis N, Seejore K, Hanafy A, Murray RD, Endocrinology (2020) Diabetes Metab 3(3):e00158
  12. Trainer PJ, Drake WM, Katznelson L, Freda PU, Herman-Bonert V, van der Lely AJ et al (2000) Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. N Engl J Med 342(16):1171–1177 · DOI · Paper page
  13. Berton AM, Prencipe N, Bertero L, Baldi M, Bima C, Corsico M et al (2022) Resistance to somatostatin analogs in Italian acromegaly patients: the MISS Study. J Clin Med.;12(1) · doi:10.3390/jcm12010025
  14. Fleseriu M, Zhang Z, Hanman K, Haria K, Houchard A, Khawaja S et al (2023) A systematic literature review to evaluate extended dosing intervals in the pharmacological management of acromegaly. Pituitary 26(1):9–41 · DOI
  15. Muhammad A, Coopmans EC, Delhanty PJD, Dallenga AHG, Haitsma IK, Janssen J et al (2018) Efficacy and safety of switching to Pasireotide in Acromegaly patients controlled with pegvisomant and somatostatin analogues: PAPE extension study. Eur J Endocrinol 179(5):269–277 · doi:10.1530/eje-18-0353
  16. Prencipe N, Bona C, Cuboni D, Parasiliti-Caprino M, Berton AM, Fenoglio LM et al (2021) Biliary adverse events in acromegaly during somatostatin receptor ligands: predictors of onset and response to ursodeoxycholic acid treatment. Pituitary 24(2):242–251 · DOI
  17. Ságová I, Mokáň M, Payer J, Vaňuga P (2022) Pegvisomant in the treatment of acromegaly. Vnitr Lek 68(E–7):17–22 · doi:10.36290/vnl.2022.101
  18. Heringer LC, de Oliveira MF, Rotta JM, Botelho RV (2016) Effect of repeated transsphenoidal surgery in recurrent or residual pituitary adenomas: a systematic review and meta-analysis. Surg Neurol Int 7:14 · DOI
  19. Almeida JP, Ruiz-Treviño AS, Liang B, Omay SB, Shetty SR, Chen YN et al (2018) Reoperation for growth hormone-secreting pituitary adenomas: report on an endonasal endoscopic series with a systematic review and meta-analysis of the literature. J Neurosurg 129(2):404–416 · doi:10.3171/2017.2.jns162673
  20. Negm HM, Al-Mahfoudh R, Pai M, Singh H, Cohen S, Dhandapani S et al (2017) Reoperative endoscopic endonasal surgery for residual or recurrent pituitary adenomas. J Neurosurg 127(2):397–408 · DOI
  21. Hannon MJ, Barkan AL, Drake WM (2016) The role of Radiotherapy in Acromegaly. Neuroendocrinology 103(1):42–49 · DOI
  22. Jenkins PJ, Bates P, Carson MN, Stewart PM, Wass JA (2006) Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly. J Clin Endocrinol Metab 91(4):1239–1245 · DOI · Paper page
  23. Minniti G, Jaffrain-Rea ML, Osti M, Esposito V, Santoro A, Solda F et al (2005) The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas. Clin Endocrinol (Oxf) 62(2):210–216 · DOI
  24. Castinetti F, Morange I, Dufour H, Regis J, Brue T (2009) Radiotherapy and radiosurgery in acromegaly. Pituitary 12(1):3–10 · DOI
  25. Knappe UJ, Petroff D, Quinkler M, Schmid SM, Schöfl C, Schopohl J et al (2020) Fractionated radiotherapy and radiosurgery in acromegaly: analysis of 352 patients from the German Acromegaly Registry. Eur J Endocrinol 182(3):275–284 · DOI
  26. Minniti G, Scaringi C, Enrici RM (2011) Radiation techniques for acromegaly. Radiat Oncol 6(1):167 · DOI

Metadata

Authors
Maroufi, S. F., Assar, M., Khorasanizadeh, M., Sabet, F. M., Sabahi, M., Dabecco, R., Adada, B., Zada, G., & Borghei-Razavi, H.
Venue
Journal of Neuro-Oncology
Published
2024-04-08
Volume
168
Issue
1
Pages
13-25
ISSN
  • 0167-594X
  • 1573-7373
Cited by
2
References
2
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Assessment of multimodal treatment options in recurrent and persistent acromegaly: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1007/s11060-024-04658-7
The paper
Maroufi, S. F., Assar, M., Khorasanizadeh, M., Sabet, F. M., Sabahi, M., Dabecco, R., Adada, B., Zada, G., & Borghei-Razavi, H. (2024). Assessment of multimodal treatment options in recurrent and persistent acromegaly: a systematic review and meta-analysis. Journal of Neuro-Oncology. https://doi.org/10.1007/s11060-024-04658-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.